Skip to main content
. 2005 May 17;9(4):R331–R343. doi: 10.1186/cc3538

Table 5.

Baseline characteristics of pediatric severe sepsis patients with purpura fulminans, meningitis, or meningococcal disease

Baseline characteristics1 No PF, MEN, or MD N = 143 PF, MEN, or MD N = 121 PF N = 87 MEN N = 50 MD N = 90
Demographics and disease severity
 Age (years), mean ± SD 6.8 ± 6.3 5.6 ± 5.8 6.1 ± 5.9 5.7 ± 6.2 5.9 ± 5.8
 Male (%) 46.2 53.7 50.6 52.0 55.9
 Caucasian (%) 63.6 86.8 90.8 80.0 92.2
 Organ dysfunctions, median; q1-q3 2.0; 1.0–3.0 2.0; 1.0–3.0 2.0; 1.0–3.0 2.0; 1.0–3.0 2.0; 1.0–3.0
 First organ dysfunction to infusion (h), mean ± SD 22.3 ± 13.3 13.0 ± 10.0 13.2 ± 9.5 12.3 ± 9.1 13.0 ± 10.2
Coagulation biomarkers
 Protein C level (%), median; q1-q3 38; 24–59 27; 19–38 29; 19–38 24; 16–41 26; 18–35
 Platelet count, median; q1-q3 115; 58–205 88; 51–142 85; 42–122 107; 67–178 87; 53–132
 APTT (s), median; q1-q3 46; 35–59 57; 41–79 57; 40–82 49; 40–70 57; 40–80
 PT (s), median; q1-q3 16; 14–21 20; 15–26 20; 16–26 17; 15–23 20; 16–25
Cardiovascular and respiratory measures
 Vasopressor (%) 70.8 87.4 90.0 81.6 87.5
 Ventilator (%) 90.6 80.0 82.9 76.3 79.2
 Cardiovascular study entry criteria (%) 82.5 93.5 97.3 90.9 96.2
 Respiratory study entry criteria (%) 64.3 34.6 37.0 34.1 30.8

1Patients with missing data were excluded from this analysis. APTT, activated partial thromboplastin time; MD, meningococcal disease; MEN, meningitis; PF, purpura fulminans; PT, prothrombin time.